We sat down with Sion Wyn, editor of GAMP 5 and FDA advisor for 21 CFR Part 11, to discuss the state of computerized system compliance in 2023.
Take a walkthrough tour of the latest industry developments, what they mean for your regulated company, and what the future holds for businesses using computerized tools for their life science activities.
